This Article Full Text Full Text (PDF) All Versions of this Article: 48/2/239    most recent 01.HYP.0000231338.41548.fcv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bochud, M. Articles by Burnier, M. Search for Related Content PubMed PubMed Citation Articles by Bochud, M. Articles by Burnier, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Metabolic Syndrome Related Collections Risk Factors Other diabetes Glucose intolerance Epidemiology

(Hypertension. 2006;48:239.)
© 2006 American Heart Association, Inc.

Original Articles

Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome

Murielle Bochud; Jürg Nussberger; Pascal Bovet; Marc R. Maillard; Robert C. Elston; Fred Paccaud; Conrad Shamlaye; Michel Burnier

From the Department of Epidemiology and Biostatistics (M. Bochud, R.C.E.), Case Western Reserve University, Cleveland, Ohio; Institut Universitaire de Médecine Sociale et Préventive (M. Bochud, P.B., F.P.), Lausanne, Switzerland; Département de Médecine et Service de Néphrologie (J.N., M.R.M., M. Burnier), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; and the Ministry of Health (P.B., C.S.), Victoria, Seychelles.

Correspondence to Michel Burnier, Division of Nephrology and Hypertension Consultation, Centre Universitaire Hospitalier Vaudois, Rue du Bugnon, 17, 1011 Lausanne, Switzerland. E-mail michel.burnier{at}chuv.ch

The aim of this study was to analyze the associations of plasma aldosterone and plasma renin activity with the metabolic syndrome and each of its components. We analyzed data from a family based study in the Seychelles made up of 356 participants (160 men and 196 women) from 69 families of African descent. In multivariable models, plasma aldosterone was associated positively (P<0.05) with blood pressure in older individuals (interaction with age, P<0.05) and with waist circumference in men (interaction with sex, P<0.05) and negatively with high-density lipoprotein cholesterol, in particular in individuals with elevated urinary potassium excretion (interaction with urinary potassium, P<0.05); plasma renin activity was significantly associated with triglycerides and fasting blood glucose. Plasma aldosterone, but not plasma renin activity, was associated with the metabolic syndrome per se, independently of the association with its separate components. The observation that plasma renin activity was associated with some components of the metabolic syndrome, whereas plasma aldosterone was associated with other components of the metabolic syndrome, suggests different underlying mechanisms. These findings reinforce previous observations suggesting that aldosterone is associated with several cardiovascular risk factors and also suggest that aldosterone might contribute to the increased cardiovascular disease risk in individuals of African descent with the metabolic syndrome.

Key Words: aldosterone • metabolism • blood pressure • genetics

This article has been cited by other articles:

				J. R. Sowers, A. Whaley-Connell, and M. Epstein Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension Ann Intern Med, June 2, 2009; 150(11): 776 - 783. [Abstract] [Full Text] [PDF]

				E. Pimenta and D. A. Calhoun Aldosterone and Metabolic Dysfunction: An Unresolved Issue Hypertension, April 1, 2009; 53(4): 585 - 586. [Full Text] [PDF]

				G. Lastra, A. Whaley-Connell, C. Manrique, J. Habibi, A. A. Gutweiler, L. Appesh, M. R. Hayden, Y. Wei, C. Ferrario, and J. R. Sowers Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E110 - E116. [Abstract] [Full Text] [PDF]

				A. W. Krug and M. Ehrhart-Bornstein Aldosterone and Metabolic Syndrome: Is Increased Aldosterone in Metabolic Syndrome Patients an Additional Risk Factor? Hypertension, May 1, 2008; 51(5): 1252 - 1258. [Full Text] [PDF]

				T. Fujita Insulin resistance and salt-sensitive hypertension in metabolic syndrome Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3102 - 3107. [Full Text] [PDF]

				R. Bentley-Lewis, G. K. Adler, T. Perlstein, E. W. Seely, P. N. Hopkins, G. H. Williams, and R. Garg Body Mass Index Predicts Aldosterone Production in Normotensive Adults on a High-Salt Diet J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4472 - 4475. [Abstract] [Full Text] [PDF]

				M. Nagase, H. Matsui, S. Shibata, T. Gotoda, and T. Fujita Salt-Induced Nephropathy in Obese Spontaneously Hypertensive Rats Via Paradoxical Activation of the Mineralocorticoid Receptor: Role of Oxidative Stress Hypertension, November 1, 2007; 50(5): 877 - 883. [Abstract] [Full Text] [PDF]

				P. Korantzopoulos, M. Elisaf, and H. J. Milionis Multifactorial intervention in metabolic syndrome targeting at prevention of chronic kidney disease ready for prime time? Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2768 - 2774. [Full Text] [PDF]

				G. Colussi, C. Catena, R. Lapenna, E. Nadalini, A. Chiuch, and L. A. Sechi Insulin Resistance and Hyperinsulinemia Are Related to Plasma Aldosterone Levels in Hypertensive Patients Diabetes Care, September 1, 2007; 30(9): 2349 - 2354. [Abstract] [Full Text] [PDF]

				E. Ingelsson, M. J. Pencina, G. H. Tofler, E. J. Benjamin, K. J. Lanier, P. F. Jacques, C. S. Fox, J. B. Meigs, D. Levy, M. G. Larson, et al. Multimarker Approach to Evaluate the Incidence of the Metabolic Syndrome and Longitudinal Changes in Metabolic Risk Factors: The Framingham Offspring Study Circulation, August 28, 2007; 116(9): 984 - 992. [Abstract] [Full Text] [PDF]

				S. Kidambi, J. M. Kotchen, C. E. Grim, H. Raff, J. Mao, R. J. Singh, and T. A. Kotchen Association of Adrenal Steroids With Hypertension and the Metabolic Syndrome in Blacks Hypertension, March 1, 2007; 49(3): 704 - 711. [Abstract] [Full Text] [PDF]

				D. A. Calhoun Aldosterone and Cardiovascular Disease: Smoke and Fire Circulation, December 12, 2006; 114(24): 2572 - 2574. [Full Text] [PDF]

				M. Nagase, S. Yoshida, S. Shibata, T. Nagase, T. Gotoda, K. Ando, and T. Fujita Enhanced Aldosterone Signaling in the Early Nephropathy of Rats with Metabolic Syndrome: Possible Contribution of Fat-Derived Factors J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3438 - 3446. [Abstract] [Full Text] [PDF]

				M. Burnier The Renin-Angiotensin-Aldosterone System and Metabolic Syndrome Journal of Renin-Angiotensin-Aldosterone System, September 1, 2006; 7(3): 184 - 184. [PDF]